Auf dieser Seite
VTVT Klasse A vTv Therapeutics Inc. - Class A Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$30,57
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$19,5052-Wochen-Tief
$44,0052-Wochen-Hoch
Umsatz
$0
Ihre Abzeichen
52W-Spanne
$20–$44
Analystenbewertung
BUY
Kursziel
$55
P/E
·
ROE
-70.4%
Nettogewinnmarge
-12.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
VTVT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$30.57
Umsatz
$0
ROE
-70.4%
52W-Spanne
$20–$44
VTVT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 21. November 2023 | 1-for-40 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$02016-12-31 → 2025-12-31
Freier Cashflow·2017-12-31 → 2024-12-31
Nettogewinnmarge-12.9%2017-12-31 → 2024-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | VTVT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -25.1% | · | -2891.1% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -17.4% | · | -2723.4% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -12.9% | · | -2723.4% | Spitzenklasse | |
| ROA | -42.1%5-Jahres-Durchschnitt ≈-68.5% | ≈-68.5% | -66.5% | Spitzenklasse | |
| ROE | -70.4%5-Jahres-Durchschnitt ≈111.7% | ≈111.7% | -108.8% | Spitzenklasse | |
| ROIC | -50.9%5-Jahres-Durchschnitt ≈17.6% | ≈17.6% | -73.1% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | VTVT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 12.55-Jahres-Durchschnitt ≈6.3 | ≈6.3 | 3.5 | Starke Liquidität | |
| Quick Ratio | 13.45-Jahres-Durchschnitt ≈5.7 | ≈5.7 | 3.0 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | VTVT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -36.7% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | VTVT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.0 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$0.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
356.0%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-1.05 | $-1.01 | -4.0% |
| 31. März 2026 | Mai 13, 2026 | $1.94 | $-0.10 | 2102.1% |
| 31. Dezember 2025 | $-0.58 | $-1.11 | 47.7% | |
| 30. September 2025 | $-1.08 | $-1.00 | -8.0% | |
| 30. Juni 2025 | $-0.92 | $-0.84 | -9.3% | |
| 31. März 2025 | $-0.77 | $-0.83 | 7.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1M | $0 | $2M | $4M | $6M | $3M | $12M | $291.0K | $634.0K | $519.0K | $2M | |
| R&D Expense | $18M | $12M | $14M | $12M | $13M | $11M | $15M | $23M | $40M | $45M | $27M | $17M | |
| SG&A Expense | $15M | $14M | $12M | $12M | $12M | $7M | $9M | $9M | $11M | $10M | $9M | $12M | |
| Operating Expenses | $33M | $25M | $26M | $25M | $26M | $18M | $24M | $32M | $51M | $56M | $39M | $30M | |
| Operating Income | $-33M | $-24M | $-26M | $-23M | $-22M | $-12M | $-21M | $-20M | $-51M | $-55M | $-38M | $-29M | |
| Interest Expense | · | · | $13.0K | $15.0K | $12.0K | $692.0K | $2M | $3M | $3M | $398.0K | $108.0K | $286.0K | |
| Interest Income | $0 | $0 | $100.0K | $352.0K | $0 | $0 | $53.0K | $61.0K | $117.0K | $87.0K | $40.0K | $4.0K | |
| Other Non-op | · | · | $-1M | $-4M | $2M | $0 | $1.0K | $46.0K | · | $-22.0K | $-838.0K | $-503.0K | |
| Pretax Income | $-31M | $-23M | $-26M | $-25M | $-18M | $-13M | $-22M | $-24M | $-54M | $-55M | $-41M | $-36M | |
| Income Tax | $0 | $100.0K | $0 | $200.0K | $115.0K | $0 | $100.0K | $200.0K | $800.0K | $0 | $0 | $0 | |
| Net Income | $-27M | $-18M | $-20M | $-19M | $-13M | $-8M | $-13M | $-8M | $-16M | $-16M | $-27M | $-36M | |
| EBITDA | $-33M | $-24M | $-26M | $-23M | · | $-12M | $-21M | $-20M | $-51M | · | $-38M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $37M | $9M | $12M | $13M | $6M | $2M | $2M | $12M | $52M | $88M | $1M | |
| Receivables | · | $62.0K | $102.0K | $173.0K | $57.0K | $158.0K | $5.0K | $0 | $8M | $0 | $69.0K | · | |
| Prepaid Expense | $743.0K | $1M | $1M | $3M | $2M | $939.0K | $806.0K | $666.0K | $442.0K | $612.0K | $1M | $97.0K | |
| Other Current Assets | $218.0K | $175.0K | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $90M | $38M | $11M | $27M | $16M | $7M | $3M | $3M | $20M | $52M | $89M | $2M | |
| PP&E (Net) | · | $28.0K | $117.0K | $207.0K | $278.0K | $367.0K | $461.0K | $70.0K | $283.0K | $444.0K | $624.0K | $4M | |
| PP&E (Gross) | · | $536.0K | $604.0K | $604.0K | $583.0K | $583.0K | $609.0K | $9M | $9M | $11M | $12M | $16M | |
| Accum. Depreciation | · | $508.0K | $487.0K | $397.0K | $305.0K | $216.0K | $148.0K | $8M | $9M | $10M | $11M | $12M | |
| Other Non-current Assets | $6.0K | $153.0K | · | · | · | · | · | · | · | $2M | $2M | $110.0K | |
| Total Assets | $90M | $38M | $11M | $33M | $25M | $15M | $9M | $9M | $28M | $54M | $92M | $13M | |
| Accounts Payable | $7M | $939.0K | $4M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $2M | |
| Short-term Debt | · | $0 | $191.0K | $224.0K | $256.0K | $84.0K | $144.0K | $216.0K | $4M | · | · | $155.0K | |
| Current Liabilities | $7M | $5M | $11M | $8M | $8M | $6M | $13M | $19M | $27M | $11M | $8M | $7M | |
| Capital Leases | · | $0 | $169.0K | $338.0K | $492.0K | $676.0K | $831.0K | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $50.0K | $260.0K | $260.0K | $290.0K | $433.0K | $245.0K | $4M | |
| Total Liabilities | $25M | $24M | $30M | $27M | $10M | $11M | $18M | $29M | $48M | $23M | $8M | $74M | |
| Long-term Debt | · | · | · | · | · | · | $5M | $15M | · | $11M | · | · | |
| Total Debt | · | $0 | $191.0K | $224.0K | · | $84.0K | $144.0K | $216.0K | $4M | · | · | · | |
| Retained Earnings | $-327M | $-300M | $-281M | $-266M | $-249M | $-290M | $-234M | $-234M | $-279M | $-215M | $-196M | · | |
| Stockholders' Equity | $64M | $12M | $-25M | $-11M | $-10M | $-80M | $-49M | $-83M | $-151M | $-91M | $-78M | $-499M | |
| Liabilities + Equity | $90M | $38M | $11M | $33M | $25M | $15M | $9M | $9M | $28M | $54M | $92M | $13M |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $3M | $2M | $1M | $2M | $1M | $2M | $3M | $4M | $3M | $859.0K | · | |
| Operating Cash Flow | $-25M | $-25M | $-19M | $-16M | $-19M | $-18M | $-23M | $-27M | $-45M | $-48M | $-37M | $-31M | |
| CapEx | · | $0 | $0 | $21.0K | $0 | $0 | $70.0K | $5.0K | $57.0K | $87.0K | $104.0K | $33.0K | |
| Investing Cash Flow | $0 | $0 | $4M | $-21.0K | $0 | $0 | $242.0K | $7.0K | $-25.0K | $-83.0K | · | · | |
| Stock Issued | $0 | $2M | $0 | $0 | $27M | $14M | $5M | $22M | · | · | · | · | |
| Net Stock Activity | $0 | $2M | $0 | $0 | · | $14M | $5M | $22M | · | · | · | · | |
| Financing Cash Flow | $77M | $53M | $12M | $15M | $27M | $19M | $23M | $17M | $8M | $12M | · | · | |
| Net Change in Cash | $52M | $27M | $-3M | $-1M | $8M | $1M | $94.0K | $-10M | $-37M | $-36M | $87M | $295.0K | |
| Taxes Paid | $0 | $100.0K | $0 | $200.0K | $115.0K | $0 | $100.0K | $1M | · | · | · | · | |
| Free Cash Flow | · | $-25M | $-19M | $-16M | · | · | $-23M | $-27M | $-45M | · | $-37M | · | |
| Levered FCF | · | · | $-19M | $-16M | · | · | $-25M | $-30M | $-48M | · | $-37M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -2377.6% | · | -1116.9% | · | -184.8% | -755.9% | -159.4% | -17416.5% | · | -7349.1% | · | |
| Net Margin | · | -1815.3% | · | -949.6% | · | -132.5% | -471.9% | -63.6% | -5547.8% | · | -5298.3% | · | |
| Pretax Margin | · | -2222.7% | · | -1232.6% | · | -199.6% | -790.1% | -190.2% | -18504.1% | · | -7920.4% | · | |
| EBITDA Margin | · | -2377.6% | · | -1116.9% | · | -184.8% | -755.9% | -159.4% | -17416.5% | · | -7349.1% | · | |
| ROA | -42.1% | -74.9% | -91.5% | -65.3% | · | -70.7% | -146.4% | -43.4% | -39.2% | · | -52.6% | · | |
| ROE | -70.4% | 295.8% | 81.1% | 140.3% | · | 12.9% | 27.1% | 12.5% | 13.3% | · | 9.5% | · | |
| ROIC | -50.9% | -199.1% | 104.1% | 216.1% | · | · | 42.9% | 24.2% | 35.0% | · | 48.9% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.5 | 7.3 | 1.0 | 3.5 | · | 1.1 | 0.2 | 0.2 | 0.8 | · | 11.5 | · | |
| Quick Ratio | 13.4 | 7.1 | 0.9 | 1.6 | · | 0.9 | 0.1 | 0.1 | 0.7 | · | 11.4 | · | |
| Debt / Equity | · | 0.0 | -0.0 | -0.0 | · | -0.0 | -0.0 | -0.0 | -0.0 | · | · | · | |
| Interest Coverage | · | · | -1961.7 | -1502.7 | · | -17.1 | -11.4 | -6.0 | -16.4 | · | -560.9 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.1 | · | 0.5 | 0.3 | 0.7 | 0.0 | · | 0.0 | · | |
| Receivables Turnover | · | 12.4 | 0.0 | 17.5 | · | 78.7 | 1105.6 | 3.1 | 0.1 | · | 15.0 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -49.6% | -37.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -36.7% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $1M | $0 | $2M | $4M | $6M | $3M | $12M | $291.0K | $634.0K | $519.0K | · | |
| Net Income TTM | $-27M | $-18M | $-20M | $-19M | $-13M | $-8M | $-13M | $-8M | $-16M | $-16M | $-27M | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $37M | $0 | $0 | $0 | $0 | $17.0K | $0 | $0 | $1M | $0 | $0 | $0 | $0 | $9.0K | $2M | |
| R&D Expense | $9M | $9M | $4M | $7M | $4M | $3M | $2M | $3M | $3M | $3M | $3M | $5M | $4M | $3M | $2M | $3M | |
| SG&A Expense | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $5M | |
| Operating Expenses | $14M | $14M | $8M | $11M | $8M | $7M | $5M | $7M | $7M | $7M | $5M | $8M | $7M | $6M | $4M | $8M | |
| Operating Income | $-14M | $23M | $-8M | $-11M | $-8M | $-7M | $-5M | $-7M | $-7M | $-6M | $-5M | $-8M | $-7M | $-6M | $-4M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $4.0K | $2.0K | $0 | $8.0K | $0 | $1.0K | |
| Interest Income | $812.0K | $838.0K | $-1M | $399.0K | $275.0K | $331.0K | $-1M | $504.0K | $553.0K | $79.0K | $0 | $0 | $100.0K | $150.0K | $50.0K | $0 | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $403.0K | $-167.0K | $-3M | |
| Pretax Income | $-13M | $24M | $-7M | $-10M | $-7M | $-6M | $-4M | $-6M | $-6M | $-6M | $-9M | $-7M | $-6M | $-5M | $-4M | $-9M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $100.0K | $0 | $0 | $0 | $0 | $0 | $200.0K | |
| Net Income | $-13M | $24M | $-7M | $-9M | $-6M | $-5M | $-4M | $-5M | $-5M | $-5M | $-7M | $-6M | $-4M | $-4M | $-3M | $-7M | |
| EBITDA | $-14M | $23M | · | $-11M | $-8M | $-7M | · | $-7M | $-7M | $-6M | $-5M | $-8M | $-7M | $-6M | $-4M | $-6M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $87M | $98M | $89M | $99M | $26M | $31M | $37M | $42M | $46M | $52M | $8M | $13M | $19M | $15M | $18M | $12M | |
| Receivables | · | · | · | · | · | · | · | $242.0K | $306.0K | $981.0K | $0 | $0 | $0 | $57.0K | $77.0K | $57.0K | |
| Prepaid Expense | $416.0K | $521.0K | $961.0K | $840.0K | $359.0K | $742.0K | $1M | $1M | $303.0K | $571.0K | $2M | $1M | $2M | $1M | $643.0K | $1M | |
| Other Current Assets | $530.0K | $201.0K | $218.0K | $112.0K | $93.0K | $115.0K | $175.0K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $88M | $99M | $90M | $99M | $26M | $32M | $38M | $43M | $46M | $54M | $10M | $14M | $21M | $29M | $31M | $14M | |
| PP&E (Net) | · | · | · | $14.0K | $16.0K | $19.0K | · | $50.0K | $72.0K | $95.0K | $140.0K | $162.0K | $185.0K | $230.0K | $254.0K | $255.0K | |
| Other Non-current Assets | $4.0K | $5.0K | $6.0K | · | · | · | $153.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $88M | $99M | $90M | $99M | $26M | $32M | $38M | $43M | $46M | $54M | $15M | $22M | $29M | $36M | $37M | $20M | |
| Accounts Payable | $7M | $7M | $1M | $10M | $5M | $4M | $939.0K | $6M | $7M | $9M | $10M | $9M | $8M | $7M | $10M | $12M | |
| Short-term Debt | · | · | · | $328.0K | · | · | · | $0 | $0 | $0 | $473.0K | $0 | $0 | $557.0K | $0 | · | |
| Current Liabilities | $7M | $7M | $7M | $10M | $5M | $4M | $5M | $6M | $7M | $9M | $10M | $9M | $9M | $7M | $10M | $13M | |
| Capital Leases | · | · | · | · | · | · | · | $32.0K | $79.0K | $125.0K | $213.0K | $256.0K | $297.0K | $333.0K | $388.0K | $441.0K | |
| Total Liabilities | $9M | $9M | $25M | $29M | $24M | $23M | $24M | $25M | $26M | $28M | $29M | $29M | $28M | $28M | $30M | $14M | |
| Total Debt | · | · | · | $328.0K | · | · | · | $0 | $0 | $0 | $473.0K | $0 | $0 | $557.0K | $0 | · | |
| Retained Earnings | $-316M | $-303M | $-327M | $-320M | $-311M | $-305M | $-300M | $-296M | $-291M | $-286M | $-281M | $-281M | $-274M | $-267M | $-253M | $-248M | |
| Stockholders' Equity | $79M | $90M | $64M | $71M | $3M | $8M | $12M | $15M | $16M | $21M | $-25M | $-25M | $-19M | $-17M | $-9M | $-8M | |
| Liabilities + Equity | $88M | $99M | $90M | $99M | $26M | $32M | $38M | $43M | $46M | $54M | $15M | $22M | $29M | $36M | $37M | $20M |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $1M | $1M | $1M | $930.0K | $813.0K | $825.0K | $853.0K | $859.0K | $220.0K | $433.0K | $399.0K | $343.0K | $338.0K | $167.0K | $476.0K | |
| Operating Cash Flow | $-11M | $9M | $-9M | $-5M | $-5M | $-6M | $-5M | $-6M | $-7M | $-7M | $-5M | $-6M | $-5M | $-9M | $706.0K | $-1M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | · | · | $0 | · | · | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | $0 | · | · | $0 | · | · | |
| Stock Issued | · | · | $0 | · | · | · | $0 | · | · | · | $0 | · | · | $5M | · | · | |
| Financing Cash Flow | · | · | $-321.0K | $78M | $-42.0K | $0 | $0 | $2M | $0 | $50M | $473.0K | $0 | $12M | $6M | $5M | $-256.0K | |
| Net Change in Cash | $-11M | $9M | $-10M | $73M | $-5M | $-6M | $-5M | $-4M | $-7M | $43M | $-4M | $-6M | $7M | $-3M | $6M | $-1M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 63.1% | · | · | · | · | · | · | · | -562.7% | · | · | · | · | -44744.4% | -324.1% | |
| Net Margin | · | 65.5% | · | · | · | · | · | · | · | -486.5% | · | · | · | · | -35011.1% | -350.3% | |
| Pretax Margin | · | 65.5% | · | · | · | · | · | · | · | -591.9% | · | · | · | · | -45455.6% | -461.2% | |
| EBITDA Margin | · | 63.1% | · | · | · | · | · | · | · | -562.7% | · | · | · | · | -44744.4% | -324.1% | |
| ROA | -22.9% | 36.9% | · | -12.2% | -16.6% | -11.8% | · | -16.5% | -15.0% | -11.7% | -26.4% | -18.9% | -18.4% | -12.7% | -10.8% | -37.9% | |
| ROE | -32.1% | 49.3% | · | -20.3% | -62.9% | -35.5% | · | 93.6% | 117.6% | -606.6% | 31.8% | 33.2% | 33.0% | 22.4% | 11.2% | 21.8% | |
| ROIC | -17.7% | 25.9% | · | -15.1% | -279.5% | -82.1% | · | -43.4% | -43.4% | -27.5% | 21.7% | 31.6% | 38.7% | 35.5% | 47.2% | 81.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.5 | 14.4 | · | 9.8 | 5.0 | 7.4 | · | 6.7 | 6.6 | 6.0 | 1.0 | 1.5 | 2.4 | 3.9 | 3.1 | 1.1 | |
| Quick Ratio | 12.3 | 14.3 | · | 9.7 | 4.9 | 7.2 | · | 6.5 | 6.6 | 6.0 | 0.8 | 1.4 | 2.2 | 2.1 | 1.8 | 1.0 | |
| Debt / Equity | · | · | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.0 | -0.0 | 0.0 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -1342.0 | -4000.0 | · | -711.1 | · | -6481.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.6 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Receivables Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 67.8 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $37M | $37M | · | $17.0K | $17.0K | $17.0K | · | $1M | $1M | $1M | $9.0K | $9.0K | $18.0K | $2M | $5M | $5M | |
| Net Income TTM | $-5M | $2M | · | $-23M | $-20M | $-19M | · | $-18M | $-20M | $-21M | $-22M | $-19M | $-17M | $-21M | $-18M | $-16M |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $0 | $1M | $0 | $2M | $4M |
| Betriebsgewinnmarge % | · | -2377.6% | · | -1116.9% | · |
| Nettoergebnis | $-27M | $-18M | $-20M | $-19M | $-13M |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | 0.0 | -0.0 | -0.0 | · |
| Liquiditätsgrad | 13.5 | 7.3 | 1.0 | 3.5 | · |
| Quick Ratio | 13.4 | 7.1 | 0.9 | 1.6 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | $-25M | $-19M | $-16M | · |
Institutionelle Eigentümer (13F) 47 Einreicher · $63.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
47
Gehaltener Wert
$63.6M
Neue Positionen
17
Geschlossene Positionen
6
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 17 (+5 vs. Vorquartal) | 6 (+3 vs. Vorquartal) | 6 (-1 vs. Vorquartal) | 8 (+4 vs. Vorquartal) | +120K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | $11.238.374 | 298.496 | 17,67% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $10.160.756 | 269.874 | 15,97% | Aktien |
| FMR LLC | $9.803.721 | 260.391 | 15,41% | Aktien |
| Siren, L.L.C. | $6.136.950 | 163.000 | 9,65% | Aktien |
| BAKER BROS. ADVISORS LP | $5.584.022 | 148.314 | 8,78% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.556.532 | 94.463 | 5,59% | Aktien |
| VANGUARD GROUP INC | $3.335.166 | 83.400 | 5,24% | Aktien |
| Trails Edge Capital Partners, LP | $3.207.479 | 85.192 | 5,04% | Aktien |
| Aisling Capital Management LP | $1.882.500 | 50.000 | 2,96% | Aktien |
| MARSHALL WACE, LLP | $1.489.435 | 39.560 | 2,34% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.223.392 | 32.470 | 1,92% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $657.143 | 17.454 | 1,03% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $611.398 | 16.239 | 0,96% | Aktien |
| BlackRock, Inc. | $554.622 | 14.731 | 0,87% | Aktien |
| JANE STREET GROUP, LLC | $515.918 | 13.703 | 0,81% | Aktien |
| STATE STREET CORP | $461.815 | 12.266 | 0,73% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $432.448 | 11.486 | 0,68% | Aktien |
| Verdad Advisers, LP | $338.699 | 8.996 | 0,53% | Aktien |
| Integrated Quantitative Investments LLC | $309.106 | 8.210 | 0,49% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $302.066 | 8.023 | 0,47% | Aktien |
| Quadrature Capital Ltd | $237.383 | 6.305 | 0,37% | Aktien |
| Trexquant Investment LP | $234.936 | 6.240 | 0,37% | Aktien |
| NORTHERN TRUST CORP | $230.531 | 6.123 | 0,36% | Aktien |
| Pathstone Holdings, LLC | $228.664 | 6.073 | 0,36% | Aktien |
| Point72 Asset Management, L.P. | $223.905 | 5.947 | 0,35% | Aktien |
| CITADEL ADVISORS LLC | $222.361 | 5.906 | 0,35% | Aktien |
| China Universal Asset Management Co., Ltd. | $94.125 | 2.500 | 0,15% | Aktien |
| UBS Group AG | $81.889 | 2.175 | 0,13% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $67.845 | 1.802 | 0,11% | Aktien |
| Vanguard Global Advisers, LLC | $48.004 | 1.275 | 0,08% | Aktien |
| OSAIC HOLDINGS, INC. | $38.402 | 1.020 | 0,06% | Aktien |
| MORGAN STANLEY | $37.989 | 1.009 | 0,06% | Aktien |
| VALLEY NATIONAL ADVISERS INC | $36.897 | 980 | 0,06% | Aktien |
| Farther Finance Advisors, LLC | $10.655 | 283 | 0,02% | Aktien |
| Strengthening Families & Communities, LLC | $6.513 | 173 | 0,01% | Aktien |
| State of Wyoming | $5.535 | 147 | 0,01% | Aktien |
| Truvestments Capital LLC | $5.384 | 143 | 0,01% | Aktien |
| Activest Wealth Management | $1.883 | 50 | 0,00% | Aktien |
| CoreCap Advisors, LLC | $1.694 | 45 | 0,00% | Aktien |
| Parallel Advisors, LLC | $1.431 | 38 | 0,00% | Aktien |
| Sunbelt Securities, Inc. | $595 | 15 | 0,00% | Aktien |
| HRT FINANCIAL LP | $223 | 5.923 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $75 | 2 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $75 | 2 | 0,00% | Aktien |
| Strategic Wealth Partners, Ltd. | $38 | 1 | 0,00% | Aktien |
| BESSEMER GROUP INC | $4 | 112 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $0 | 3 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC, Srinivas Akkaraju ×4 Einreichungen | 9. Dezember 2025 | 9,90% | Änderung | · | SEC |
| The ROP Revocable Trust dated 1/9/2018, MacAndrews & Forbes Incorporated, MacAndrews & Forbes LLC, MacAndrews & Forbes Group LLC, MFV Holdings One LLC, M&F TTP Holdings LLC, M&F TTP Holdings Two LLC, RLX Holdings One LLC ×29 Einreichungen | 22. März 2024 | · | Erste Einreichung | · | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker | 5. März 2024 | · | Erste Einreichung | · | SEC |
| G42 Investments AI Holding RSC Ltd, Tahnoon Bin Zayed S. Al-Nahyan | 10. Juni 2022 | · | Erste Einreichung | Vorstandskampagne | SEC |
| MacAndrews & Forbes Incorporated, MacAndrews & Forbes LLC, MacAndrews & Forbes Group LLC, MFV Holdings One LLC, M&F TTP Holdings LLC, M&F TTP Holdings Two LLC ×17 Einreichungen | 28. Dezember 2018 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 24 Insider · 7 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Rich S. Nelson | Acting Chief Executive Officer | 3. März 2022 A | 10.000 | 0 | 0 | $0 |
| Deepa Prasad | President and CEO | 19. Oktober 2021 A | · | 0 | 0 | $0 |
| Stephen L. Holcombe | President & CEO | 7. Dezember 2020 A | · | 0 | 0 | $0 |
| Michael Stephen Tung | EVP & CFO | 17. Februar 2026 A | · | 0 | 0 | $0 |
| Steven L. Tuch | Chief Financial Officer | 27. Februar 2024 A | · | 0 | 0 | $0 |
| Rudy Howard | CFO & Secretary | 7. Dezember 2020 A | 5.000 | 0 | 0 | $0 |
| Larry Douglas Altstiel | Chief Medical Officer | 10. März 2017 A | · | 0 | 0 | $0 |
| Fahed Al-Marzooqi | Direktor | 26. Juni 2026 A | · | 0 | 0 | $0 |
| Anne M. Phillips | Direktor | 26. Juni 2026 A | · | 0 | 0 | $0 |
| Srinivas Akkaraju | Direktor | 26. Juni 2026 A | 106.000 | 0 | 0 | $0 |
| Daniel K Spiegelman | Direktor | 26. Juni 2026 A | · | 0 | 0 | $0 |
| Chandresh Harjivan | Direktor | 19. Juni 2023 A | · | 0 | 0 | $0 |
| Keith R. Harris | Direktor | 19. Juni 2023 A | · | 0 | 0 | $0 |
| Howard L. Weiner | Direktor | 19. Juni 2023 A | · | 0 | 0 | $0 |
| John A Fry | Direktor | 19. Juni 2023 A | 61.000 | 0 | 0 | $0 |
| Hersh Kozlov | Direktor | 19. Juni 2023 A | 25.000 | 0 | 0 | $0 |
| Jonathan Isaacsohn | Direktor | 17. August 2022 A | · | 0 | 0 | $0 |
| Noel Joseph Spiegel | Direktor | 3. Mai 2021 A | 6.000 | 0 | 0 | $0 |
| Jeffrey B Kindler | Direktor | 11. Juni 2020 A | 35.000 | 0 | 0 | $0 |
| Paul G Savas | Direktor | 6. September 2018 P | 91.781 | 0 | 0 | $0 |
| Craig C Parker | Direktor | 30. April 2018 A | · | 0 | 0 | $0 |
| Steven Michael Cohen | Direktor | 4. August 2015 P | 5.000 | 0 | 0 | $0 |
| Ronald O Perelman | 10%-Eigentümer | 20. Dezember 2021 S | 36.519.212 | 0 | 0 | $0 |
| Paul J Sekhri | · | 17. Februar 2026 A | 5.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 4 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,52% | 3.748 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,02% | 7.186 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 31.402 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 60.763 SH | 19. August 2026 | Täglich |
VTVT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 11 Analysten
KAUF
Median-Ziel
$57.00
+86,5%
3 27,3%
Starker Kauf
7 63,6%
Kauf
1 9,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
7 Analysten · 2026-10-01Mittelwert-Ziel $54.71 +79,0%
← Unter allen Zielen
Aktueller Preis $30.57
Tief$42.00
Mittelwert$54.71
Hoch$67.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VTVT | · | · | · | · | -70.4% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| HURA | · | -1.2 | · | · | · | · |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | · |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
| UNCY | $128M | -3.5 | -29.0% | · | -113.9% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026